Patients
30.0 % of people
People aged 65 and over, Japan, 2025 (World Bank).
Compare every country on the Public Health Dashboard
Updated
Reviewed by Chandani Patel
Japan Elderly Nutrition Products Market Industry Trends and Forecast to 2034: Segmented by (Product, Setting, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$1.29 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $1.55 Bn | — | — |
| 2025 (base) | $1.65 Bn | +$102.4 Mn | — |
| 2026 (forecast) | $1.76 Bn | +$109.2 Mn | +6.6% |
| 2027 (forecast) | $1.88 Bn | +$116.4 Mn | +13.6% |
| 2028 (forecast) | $2.00 Bn | +$124.1 Mn | +21.1% |
| 2029 (forecast) | $2.14 Bn | +$132.3 Mn | +29.1% |
| 2030 (forecast) | $2.28 Bn | +$141.0 Mn | +37.7% |
| 2031 (forecast) | $2.43 Bn | +$150.3 Mn | +46.7% |
| 2032 (forecast) | $2.59 Bn | +$160.2 Mn | +56.4% |
| 2033 (forecast) | $2.76 Bn | +$170.8 Mn | +66.7% |
| 2034 (forecast) | $2.94 Bn | +$182.1 Mn | +77.8% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $1.65 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $2.94 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 6.6% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, setting and distribution channel (see all) |
| Key players | Abbott Laboratories, Nestle, Danone Nutricia, Fresenius Kabi AG, Ajinomoto Co (see all) |
| Regulator in Japan | PMDA and Consumer Affairs AgencySource: Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.Source: Consumer Affairs Agency. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Elderly nutrition products are foods and drinks designed for older adults, such as high-protein shakes, texture-modified meals and oral supplements.
Key segments of the elderly Nutrition Products market include product (Oral Nutritional Supplements, Texture-Modified Foods and Protein Fortified Foods) and setting (Home, Hospitals and Care Homes).
An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the elderly Nutrition Products market. Older adults and their families are spending more on staying active and independent.
Preventive care, personalised plans based on biomarkers and home-based services give the elderly Nutrition Products market room to grow, especially in fast-ageing countries in Asia and Europe.
Limited clinical proof for some longevity products, high out-of-pocket costs, regulation that does not treat ageing as a disease and uneven access hold back the elderly Nutrition Products market.
The elderly Nutrition Products market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Drugs are reviewed by the Pharmaceuticals and Medical Devices Agency (PMDA) and approved by the Ministry of Health, Labour and Welfare (MHLW).[1] Foods with health claims, such as FOSHU and Foods with Function Claims, come under the Consumer Affairs Agency.[2] People aged 65 and over: 30.0% of people in 2025, the latest World Bank figure for Japan.[3]
[1] Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.
[2] Consumer Affairs Agency. Checked 14 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 18 Nov 2026.
Food and supplement rules, labelling and health-claim regulations govern elderly Nutrition Products products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in Japan.
What doctors and scientists are doing in Elderly Nutrition Products right now, from free public sources.
30.0 % of people
People aged 65 and over, Japan, 2025 (World Bank).
Compare every country on the Public Health DashboardSources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 18 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, People aged 65 and over (% of people). Retrieved 18 Nov 2026.
[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 18 Nov 2026.
[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 18 Nov 2026.
From our blog
Japan
Japan
Japan
Japan
Japan
Japan
Healthcare Services · Japan
Digital Health · Japan
Pharmaceuticals · Japan
Medical Devices · Japan
Medical Devices · Japan
Medical Devices · Japan